EMILY KASE: Open Payments
NPI 1831557925 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,809 in 131 payments from 25 companies in 2025. Trend: 2023 $1,178 · 2024 $1,920 · 2025 $2,809
Food & beverage: $2,809
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $488 |
| Janssen Biotech, Inc. | 15 | $256 |
| E.R. Squibb & Sons, L.L.C. | 6 | $231 |
| LEO Pharma Inc. | 9 | $222 |
| ABBVIE INC. | 14 | $214 |
| GENZYME CORPORATION | 6 | $202 |
| Galderma Laboratories, L.P. | 17 | $193 |
| Regeneron Healthcare Solutions, Inc. | 6 | $186 |
| Incyte Corporation | 6 | $123 |
| Organon LLC | 10 | $114 |
Products named: Bimzelx, DUPIXENT, TREMFYA, Sotyktu, NEMLUVIO, SKYRIZI, OPZELURA, ADBRY.
Industry payments across AZ — which companies pay providers there.
